Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of EMPAGLINAZ 25 vs JARDIANCE 25 mg in healthy Thai adult volunteers under fasting conditions
TCTR20241215007Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of empagliflozin (2 arms), sponsored by Bio-innova. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
empagliflozin
Beyond the preview
Go deeper on TCTR20241215007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241215007.